- Ragweed Allergy
- Atrial Fibrillation
- Psoriasis
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Ragweed Allergy
This study will evaluate the safety and effectiveness of an investigational drug. You must be 18 to 50 and have a history of ragweed allergy to qualify.
The research site is in Houston, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/allergies.aspx.
-----
Atrial Fibrillation
This study of atrial fibrillation is recruiting candidates. The research site is in Philadelphia, Penn.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/atrial_fibrillation.aspx.
-----
Psoriasis
This study will evaluate an investigational medication for psoriasis, a disorder that affects the skin and joints.
The research site is in Baltimore, Md.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/psoriasis.aspx.
-----
Copyright 2009 ClinicalConnection.com. All rights reserved.
Copyright © 2011 HealthDay. All rights reserved.
Reader Comments